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need not be stoichiometric with
each thin filament, nor does
nebulin regulate filament lengths
in a binary, all-or-nothing fashion.
As the numbers of nebulins per
sarcomere are decreased, the
local concentration of
tropomodulin is diminished,
leading to lower effective capping
activity, increased actin assembly
and uniformly longer thin
filaments (Figure 1B). This model
is also consistent with the
dependence of thin filament
length on tropomodulin
concentrations [15–17].
How can the question of whether
nebulin acts as a molecular ruler or
a cap locator be resolved? The
gold standard of proof for a
molecular ruler is generally believed
to be genetic replacement with
ruler molecules of altered lengths,
leading to corresponding predicted
changes in filament lengths [5]. But
this approach would not rule out a
concentrative mechanism in which
the M1M2M3 domain regulates
tropomodulin capping at altered
distances. Instead, the template
function (the modular repeats) and
the cap locator function (the
M1M2M3 domain) must be
physically dissociated. If the
M1M2M3 domain were to be
mislocalized, then tropomodulin
capping would be increased in this
new location and filament lengths
would change correspondingly.
The muscle sarcomere is a
complex, highly ordered structure,
but the molecules that make up
the elements of this structure are
dynamic and their length control
cannot be explained by a simple
ruler mechanism. A static ruler
mechanism relying on precise
stoichiometries cannot be used to
determine sizes of dynamic
polymers. This is because to allow
for variations in filament length,
cells would have to make multiple
rulers of assorted lengths.
Instead, cells have complex layers
of regulation to allow for the reuse
of their polymer building blocks in
countless combinations and
amounts to achieve many
different outcomes. In the case of
muscle, nebulin is one part of the
combinatorial regulatory process
that defines the precise filament
lengths required for physiological
functions. Determining the
molecular mechanisms by which
muscle filament lengths are
regulated will provide new
paradigms to explain
macromolecular size control.
Dissecting the role of nebulin in
regulating filament lengths is a
good place to start.
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Much remains to be learnt about the in vivo function of specific
microRNAs. Recently, the conserved microRNA miR-1 has been found
to be essential for Drosophila development. miR-1 mutants die during
the rapid larval growth phase with severe muscle defects.Michael V. Taylor
In the last few years, the
widespread prevalence of
microRNAs encoded in the
genomes of organisms ranging
from the nematode worm,Caenorhabditis elegans, to
humans has been discovered.
MicroRNAs are short RNA
molecules, around 22 nucleotides
in length. As a group, they can
control gene expression by two
routes: promotion of mRNA
Dispatch    
R21degradation or inhibition of mRNA
translation. Their discovery has
rekindled interest in the regulation
of development by post-
transcriptional control
mechanisms.
The first microRNA, lin-4, was
described in 1993 [1] in a
‘forward’ genetic screen in C.
elegans for genes involved in the
regulation of stage-specific
events during development. This
laid down an early marker that a
microRNA could have an
interesting and specific role in
development. In the last few
years, there has been rapid
progress in many facets of
microRNA biology, all thoroughly
documented in recent reviews
[2–6]. Current estimates indicate
that animal genomes encode
several hundred microRNAs.
Moreover, recent computer-
based searches for microRNA
targets have led to suggestions
that microRNAs might regulate
the expression of as many as
20–30% of all genes [7,8].
However, much about their in vivo
roles remains to be determined
and it is striking that only a
handful of microRNAs have been
analysed in vivo using loss-of-
function mutations. A new
example has been described
recently by Sokol and Ambros [9]
who ‘knocked-out’ a conserved
microRNA, called miR-1, in the
fruitfly Drosophila and found an
intriguing phenotype in larval
development.
To knock out Drosophila miR-1
(DmiR-1), Sokol and Ambros [9]
followed the still relatively rarely
used method for targeted deletion
in Drosophila developed in Kent
Golic’s lab [10]. This identified
DmiR-1 as an essential gene
required for viability. DmiR-1
knock-outs die as small, second
instar larvae. There is growth
arrest, the larvae become
increasingly lethargic and
compromised in movement, and
larval body architecture
deteriorates, collapses and
flattens [9]. How does the
observed phenotype arise, and
what clues does this give about
the function of DmiR-1?
To answer these questions the
authors explored the effect of
DmiR-1 on muscle, mainlyFigure 1. The developmental programme of the larval musculature in Drosophila.
(A) Progenitor cell populations for the different mesodermal derivatives, including the
various muscle-types, are defined by approximately a third of the way through embryo-
genesis. At this stage, a lateral view of an embryo stained for the Twist protein shows
some of these segmentally repeated progenitors. (B) At the end of embryogenesis, all
elements of the larval musculature are in place. These muscles subsequently grow sub-
stantially and rapidly during larval life. Part of the body wall musculature in a larva is
shown visualised with myosin–GFP. (C) Two key regulators of muscle development, the
transcription factors Twist and Mef2, orchestrate the events of muscle differentiation.
Arrows indicate that Twist activates mef2 gene expression, and that both transcription
factors activate a range of target genes either directly or indirectly to control muscle
development. These targets include the genes that encode muscle proteins, e.g.
myosin, tropomyosin, and now recent work indicates that microRNAs should also be
considered amongst them [9].
Specified mesodermal
derivatives
Functional larval
musculature
Twist Mef2 Downstream genes:
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Current Biologybecause of its striking and
specific expression pattern.
DmiR-1 is expressed initially
throughout the embryonic
mesoderm, and subsequently in
the different types of larval muscle
as they differentiate [9]. After
hatching, the muscles grow
substantially during the three
larval instars; however, the
expression of DmiR-1 during
these stages has not yet been
determined. It has recently
emerged that a specific pattern of
expression, like that of DmiR-1, is
not unusual for a microRNA. A
trail-blazing study published
earlier this year shows that 78 out
of 115 conserved microRNAs
tested are expressed in specific
patterns [11]. Such descriptions
have only recently become
possible by using Locked Nucleic
Acid modified oligonucleotides
[12]. This technique for visualising
microRNA expression patterns will
have a revolutionary impact on the
field, because most microRNAs
have been identified
independently of their function.
Expression patterns will,therefore, provide important clues
as to the functions of a given
microRNA.
DmiR-1 is expressed in muscle,
so does it function there? Sokol
and Ambros [9] could not detect
muscle defects in DmiR-1 mutant
embryos, despite the specific
expression during embryogenesis,
and so turned their attention to
larvae. They undertook a range of
functional tests on the body wall,
heart, pharyngeal and visceral
muscle in first instar larvae that
argued against any general
physiological defect in the
musculature [9]. It was only in the
second instar that DmiR-1 mutant
larvae showed a severe
locomotion defect and collapse of
the musculature. Intriguingly, food
and, by implication, growth
appeared to trigger the muscle
defect and the lethality. This
conclusion is based on an
experiment in which larvae were
fed just sucrose [9]. In this
condition, wild type larvae do not
grow, but remain viable and
mobile for some two weeks.
Strikingly, DmiR-1 mutants
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growth, muscle function is
indistinguishable from wild-type.
Is the lethal DmiR-1 phenotype
due to loss of DmiR-1 function in
the muscle? Sokol and Ambros [9]
addressed this using the
Gal4/UAS system to rescue the
DmiR-1 lethal phenotype. They
used the 24B Gal4 driver [13],
which is often utilised in studies of
embryonic development to drive
expression in developing muscle.
The observed rescue is certainly
good evidence for a muscle-
specific function of DmiR-1,
although one cannot exclude the
possibility that the Gal4 driver
used drives expression in other
cell types in larvae, as it does in
pupae [14].
Sokol and Ambros [9] argue
persuasively that the observed
DmiR-1 phenotype is distinct from
that of previously described larval
arrest or muscle mutants.
However, much of the link
between the microRNA and the
phenotype remains to be
explored. For example, what goes
awry in second instar muscle? As
the authors point out, very little is
known about the rapid growth
phase of larval muscle when each
fibre grows to around one
hundred times its original size [9].
DmiR-1 may provide an entry
point to understanding this
fascinating facet of muscle
development.
How are the muscle and larval
growth phenotypes linked? A
straightforward explanation is that
compromised muscle function
affects larval growth. This is
consistent with a relatively subtle
first instar muscle phenotype,
seen before overt growth effects
[9]. Contractions of the body wall
muscle are reduced in frequency,
and delayed food ingestion
indicates weakened pharyngeal
muscle. Other explanations are
also possible. Indeed, there may
be multiple target genes, whose
expression is down-regulated by
DmiR-1, and hence multiple
aspects to the phenotype. This
highlights that the key to
understanding DmiR-1 function is
to uncover its targets. Sokol and
Ambros refer to some
unpublished work on predicting
these targets [9]. The topcandidates are apparently not
expressed in cells from the
mesoderm, and the authors
speculate that there may be
promiscuous transcription in the
very active nuclei of rapidly
growing muscles and DmiR-1’s
role is to post-transcriptionally
suppress such detrimental
expression.
How is microRNA expression
controlled? Genes encoding
microRNAs are similar to protein
encoding genes in that the
primary transcript, which is
capped, polyadenylated and can
be quite long, is produced by
RNA PolII [5]. Consistent with
this, early indications are that
control of microRNA gene
expression may be similar to that
of protein encoding genes. For
DmiR-1, Sokol and Ambros [9]
focused on two key regulators of
Drosophila muscle development,
the transcription factors Twist
and Mef2 [15]. They found that
DmiR-1 expression is regulated
by twist and may have input from
mef2, too. Similarly, major
controllers of mammalian muscle
have recently been identified as
regulators of mouse miR-1 gene
expression [16]. In muscle
development, there is still much
to be learnt about how its main
regulators orchestrate all the
events required to form fully
functional muscle tissue. This
work indicates that microRNAs
should now be placed amongst
the candidate target genes of
these regulators (Figure 1).
miR-1 is a conserved
microRNA. What else is known
about it in other species? In
vertebrates, as in Drosophila, it is
expressed in developing skeletal
and heart muscle [11, 16]. Two
functional studies have recently
been reported. First, transfection
of human miR-1 into HeLa cells
produces a global shift in gene
expression towards the profile
typical of skeletal and heart
muscle [17]. Second,
overexpression of miR-1 in mice
reduces cell proliferation during
heart development, although any
possible skeletal muscle effect
has not been reported yet [16].
No effect of DmiR-1 on the heart
has yet been described in
Drosophila [9].When the techniques of
molecular biology were first
applied to Developmental
Biology some thirty years ago,
there was a lot of attention on
post-transcriptional control
mechanisms in development.
This culminated in many seminal
findings, for example the
establishment of the Drosophila
A/P axis and the role of cyclins in
early development [18]. In more
recent times, interest waned in
this aspect of the control of gene
expression and its role in
development, but the recent
work on microRNAs rejuvenates
this field.
Most studies of muscle
development have
understandably centred on
traditional areas of Developmental
Biology, like patterning and
specification. Like some others
before them, the work described
by Sokol and Ambros [9] instead
focuses on the development of a
functional musculature. One can
anticipate a shift towards this type
of study as efforts to advance
tissue repair will require a
knowledge of how functional
tissue assembles, grows and is
maintained.
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Males and females of most
species behave rather differently,
particularly when it comes to sex.
This makes sexual behaviours
attractive models for trying to
understand innate behaviours in
general. Instead of trying to
identify all the genes and all the
neurons involved in a given
behaviour, and then figure out
how they all work, one can just
look for the genes and neurons
that make the sexes different, and
try to understand how these
genes and neurons shape the
distinct sexual behaviours of
males and females. In what might
be a major step towards this goal,
Kimura et al. [1] have now
discovered a clear difference in
neural circuitry in the brains of
male and female fruit flies. This
difference, they speculate, might
just explain why male flies do the
male thing and females do not.
Fly sex is a complicated
business. To woo a female, the
male must perform an elaborate
song-and-dance courtship ritual
[2]. The fruitless (fru) gene, the
RNA transcript of which is spliced
differently in males and females,
plays a key role during
development to lay the foundation
for this behaviour (Figure 1). In
males, fru RNA is spliced in such
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FruM proteins. Males that lack the
fru gene [3], or splice it the wrong
way [4], make a complete mess of
the courtship ritual. For the most
part, they do not even bother, and
if they do, they are just as likely to
try to woo another male as a
female. What is more, females
that splice fru RNA in the male
way, and therefore make FruM,
behave like males and try to woo
other females [4]. So, genetically,
fru seems to account for much of
the difference between male and
female sexual behaviour. Can fru
also lead us to the neuronal
circuits in the brain that make the
difference?
It turns out that FruM is made in
∼3000 neurons in the male brain,
or ∼3% of the total number of
neurons [5]. These neurons are
grouped into distinct clusters in
various regions of the brain. Are
these neurons also present in
females, and if so, what is
different about them? Because
the female fru transcripts do not
encode FruM, it has been rather
difficult to identify cells in females
that correspond to the FruM-
expressing cells in males. To
circumvent this problem, two
groups [6,7] recently used gene
targeting to insert coding
sequences for an independent
marker (GAL4) into the fru locus,
Do a Few Dead
 Difference?
 differently? Sexually dimorphic
n parts of the fly’s brain thought to
explain why males and females
?Grimson, A., Schelter, J., Castle, J.,
Bartel, D., Linsley, P., and Johnson, J.
(2005). Microarray analysis shows that
some microRNAs downregulate large
numbers of target mRNAs. Nature 433,
769–773.
18. Gilbert, S.F. (2003). Developmental
Biology, 7th edn. (Sinauer Associates,
Inc.).
Cardiff School of Biosciences, Cardiff
University, Park Place, Cardiff CF10
3TL, UK. E-mail: TaylorMV@cf.ac.uk
DOI: 10.1016/j.cub.2005.12.004replacing the alternatively spliced
exon so that the marker would be
produced in both males and
females. Surprisingly, these
studies revealed that almost all of
the FruM-producing neurons in the
male have counterparts in the
female, and at a gross level, they
seem to be wired up the same
way. Of course, this does not
exclude more subtle differences in
neuroanatomy, but without
knowing which of these ∼3000
neurons make the essential
difference, there seemed little
point to go on examining them all
at higher resolution.
Kimura et al. [1] took a different
line of attack, both technically and
strategically. They isolated a
random enhancer trap insertion
further downstream in the fru
locus, called NP21 (Figure 1).
NP21 labels many, but not all, of
the FruM neurons in males, as well
as the corresponding cells in
females. Kimura et al. [1] then
went on to characterize some of
these neurons at higher
resolution, undeterred by the lack
of behavioural data to indicate
which of them might be the most
relevant. Nevertheless, two sets of
NP21-positive neurons clearly
differed anatomically in males and
females (Figure 1). One of these,
belonging to the so-called fru-
mAL cluster [5], particularly
attracted their attention.
These neurons seem to serve as
a relay between the primary
gustatory centre of the brain and
higher brain regions thought to
integrate information from
multiple sensory modalities. There
are, on average, about 30 NP21-
positive fru-mAL cells in males
and about five in females. In a
